- Home
- Automated
- List of product information
- BURINEX TABLET 1 MG [SIN00718P]
BURINEX TABLET 1 MG [SIN00718P]
Active ingredients: BURINEX TABLET 1 MG
Product Info
BURINEX TABLET 1 MG
[SIN00718P]
Product information
Active Ingredient and Strength | BUMETANIDE - 1 MG |
Dosage Form | TABLET |
Manufacturer and Country | ALLPHAMED PHARBIL ARZNEIMITTEL GMBH - GERMANY |
Registration Number | SIN00718P |
Licence Holder | ZUELLIG PHARMA PTE. LTD. |
Forensic Classification | PRESCRIPTION ONLY MEDICINES |
Anatomical Therapeutic Chemical (ATC) code | C03CA02 |
4.1 Therapeutic indications
Burinex® is indicated whenever diuretic therapy is required in the treatment of oedema e.g. associated with congestive heart failure, cirrhosis of the liver, renal diseases including the nephrotic syndrome. Acute pulmonary oedema, drug induced fluid retention, and drug poisoning that can be treated by forced diuresis. Hypertension.
4.2 Posology and method of administration
Orally: 1 mg daily.
In refractory cases the dose can be increased gradually till a satisfactory response has been obtained. Rarely will it be necessary to exceed a dose of 4 mg daily. In high dose therapy consideration should be given to a twice daily dosing.
Children: The dose is calculated on the basis of 0.03–0.06 mg/kg daily.
Elderly: Adjust dosage according to response; a dose of 0.5 mg daily may be sufficient in some elderly patients.
Where intramuscular administration is considered appropriate a dose of 1 mg should be given initially and the dose then be adjusted according to the diuretic response.
4.3 Contraindications
For Burinex® Tablets:
Hypersensitivity to active substance or to any of the excipients
Severe electrolyte depletion
Persisting anuria
Hepatic encephalopathy including coma
